XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Class B Common Stock
Common Stock
Common Shares
Common Stock
Class B Common Stock
Capital Surplus
Retained Earnings
Retained Earnings
Common Shares
Retained Earnings
Class B Common Stock
Accumulated Other Comprehensive Loss
Balance at beginning of period at Aug. 31, 2019 $ 1,641,230     $ 1,533 $ 364 $ 84,946 $ 1,588,075     $ (33,688)
Balance at beginning of period (in shares) at Aug. 31, 2019   15,333 3,643              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 48,242           48,242      
Change in fair value of derivatives (5)                 (5)
Foreign currency translation 989                 989
Dividends declared Common Stock   $ (3,825) $ (729)         $ (3,825) $ (729)  
Repurchase of Common Stock (9,973)     (5)   (274) (9,694)      
Repurchase of common stock (in shares)   (51)                
Share-based compensation, net [1] 77         77        
Share-based awards exercised, net [2] 2     2            
Share-based awards exercised, net (in shares) [2]   16                
Balance at end of period at Nov. 30, 2019 1,676,008     1,530 364 84,749 1,622,069     (32,704)
Balance at end of period (in shares) at Nov. 30, 2019   15,298 3,643              
Balance at beginning of period at Aug. 31, 2019 1,641,230     1,533 364 84,946 1,588,075     (33,688)
Balance at beginning of period (in shares) at Aug. 31, 2019   15,333 3,643              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 82,922                  
Foreign currency translation 220                  
Pension benefit liabilities, net 350                  
Balance at end of period at Feb. 29, 2020 1,701,438     1,529 364 84,577 1,648,069     (33,101)
Balance at end of period (in shares) at Feb. 29, 2020   15,293 3,643              
Balance at beginning of period at Nov. 30, 2019 1,676,008     1,530 364 84,749 1,622,069     (32,704)
Balance at beginning of period (in shares) at Nov. 30, 2019   15,298 3,643              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 34,680           34,680      
Change in fair value of derivatives 22                 22
Foreign currency translation (769)                 (769)
Pension benefit liabilities, net 350                 350
Dividends declared Common Stock   $ (3,835) $ (729)         (3,835) (729)  
Repurchase of Common Stock (4,230)     (2)   (112) (4,116)      
Repurchase of common stock (in shares)   (21)                
Share-based compensation, net [1] (60)         (60)        
Share-based awards exercised, net [2] 1     1            
Share-based awards exercised, net (in shares) [2]   16                
Balance at end of period at Feb. 29, 2020 1,701,438     1,529 364 84,577 1,648,069     (33,101)
Balance at end of period (in shares) at Feb. 29, 2020   15,293 3,643              
Balance at beginning of period at Aug. 29, 2020 1,741,129     1,525 364 86,645 1,684,565     (31,970)
Balance at beginning of period (in shares) at Aug. 29, 2020   15,251 3,643              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 41,896           41,896      
Change in fair value of derivatives (21)                 (21)
Foreign currency translation 1,310                 1,310
Dividends declared Common Stock   $ (3,806) $ (729)         (3,806) (729)  
Repurchase of Common Stock (7,216)     (4)   (223) (6,989)      
Repurchase of common stock (in shares)   (41)                
Share-based compensation, net [1] 788         788        
Share-based awards exercised, net [2] 1     1            
Share-based awards exercised, net (in shares) [2]   11                
Balance at end of period at Nov. 28, 2020 1,773,352     1,522 364 87,210 1,714,937     (30,681)
Balance at end of period (in shares) at Nov. 28, 2020   15,221 3,643              
Balance at beginning of period at Aug. 29, 2020 1,741,129     1,525 364 86,645 1,684,565     (31,970)
Balance at beginning of period (in shares) at Aug. 29, 2020   15,251 3,643              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 74,481                  
Foreign currency translation 3,554                  
Balance at end of period at Feb. 27, 2021 1,801,110     1,523 364 86,979 1,740,737     (28,493)
Balance at end of period (in shares) at Feb. 27, 2021   15,230 3,643              
Balance at beginning of period at Nov. 28, 2020 1,773,352     1,522 364 87,210 1,714,937     (30,681)
Balance at beginning of period (in shares) at Nov. 28, 2020   15,221 3,643              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 32,585           32,585      
Change in fair value of derivatives (56)                 (56)
Foreign currency translation 2,244                 2,244
Dividends declared Common Stock   $ (3,806) $ (728)         $ (3,806) $ (728)  
Repurchase of Common Stock (2,318)     (1)   (66) (2,251)      
Repurchase of common stock (in shares)   (12)                
Share-based compensation, net [1] (165)         (165)        
Share-based awards exercised, net [2] 2     2            
Share-based awards exercised, net (in shares) [2]   21                
Balance at end of period at Feb. 27, 2021 $ 1,801,110     $ 1,523 $ 364 $ 86,979 $ 1,740,737     $ (28,493)
Balance at end of period (in shares) at Feb. 27, 2021   15,230 3,643              
[1] These amounts are shown net of any shares withheld by the Company to satisfy certain tax withholdings obligations in connection with the vesting of certain shares of restricted stock or restricted stock units.
[2] These amounts are shown net of the effect of income taxes.